Board of Directors
William Farber R. Ph. was elected as Chairman of the Board of
Directors in August 1991. From April 1993 to the end of 1993, Mr. Farber
was the President and a director of Auburn Pharmaceutical Company.
From 1990 through March 1993, Mr. Farber served as Director of Purchasing
for Major Pharmaceutical Corporation. From 1965 through 1990, Mr. Farber
was the Chief Executive Officer of Michigan Pharmacal Corporation. Mr.
Farber is a registered pharmacist in the State of Michigan.
Albert I. Wertheimer, PhD was elected a Director of the Company
in September 2004. Dr. Wertheimer has a long and distinguished career in
various aspects of pharmacy, health care, education and pharmaceutical
research. Since 2000, Dr. Wertheimer has been a professor at the School
of Pharmacy at Temple University, and director of its Center for
Pharmaceutical Health Services Research. From 1997 to 2000, Dr.
Wertheimer was Director of Outcomes Research and Management at Merck
& Co., Inc. In addition to his academic responsibilities, he is the author of
22 books and more than 360 journal articles. Dr. Wertheimer also provides
consulting services to institutions in the pharmaceutical industry. Dr.
Wertheimer’s academic experience includes professorships and other faculty
and administrative positions at several educational institutions, including the
Medical College of Virginia, St. Joseph’s University, Philadelphia College of
Pharmacy and Science and the University of Minnesota. Dr. Wertheimer’s
previous professional experience includes pharmacy services in commercial
and non-profit environments. Professor Wertheimer is a licensed pharmacist
in five states, and is a member of several health associations, including the
American Pharmacists Association and the American Public Health Association.
Dr. Wertheimer is the editor of the “Journal of Pharmaceutical Finance and
Economic Policy”; and he has been on the editorial board of the Journal of
Managed Pharmaceutical Care, Medical Care, and other healthcare journals.
Dr. Wertheimer has a Bachelor of Science Degree in Pharmacy from the
University of Buffalo, a Master of Business Administration from the State
University of New York at Buffalo, a Physical Science Doctorate from
Purdue University and a Post Doctoral Fellowship from the University of
London, St. Thomas’ Medical School.
Ronald A. West was elected a Director of the Company in January
2002. In September 2004, Mr. West was elected Vice Chairman of the
Board of Directors. Mr. West is currently a Director of Beecher Associates,
an industrialreal estate investment company, R&M Resources, an
investment and consulting services company and North East Staffing,
Inc., an employee services company. Prior to this, from 1983 to 1987,
Mr. West, financial expert for the audit committee at Lannett, served as
Chairman and Chief Executive Officer of Dura Corporation, an original
equipment manufacturer of automotive products and other engineered
equipment components. In 1987, Mr. West sold his ownership position in
Dura Corporation, at which time he retired from active management
positions. Mr. West was employed at Dura Corporation since 1969. Prior
to this, he served in various financial management positions with TRW,
Inc., Marlin Rockwell Corporation and National Machine Products Group,
a division of Standard Pressed Steel Company. Mr. West studied Business
Administration at Michigan State University and the University of Detroit.
Myron Winkelman, R. Ph. was elected a Director of the Company
in June 2003. Mr. Winkelman has significant career experience in various
aspects of pharmacy and health care. He is currently President of Winkelman
Management Consulting (WMC), which provides consulting services to
both commercial and governmental clients. He has served in this position
since 1994. Mr. Winkelman has recently managed multi-state drug purchasing
initiatives for both Medicaid and state entities. Prior to creating WMC, he
was a senior executive with ValueRx, a large pharmacy benefits manager,
and served for many years as a senior executive for the Revco, Rite Aid and
Perry Drug chains. While at ValueRx, Mr. Winkelman served on the Board of
Directors of the Pharmaceutical Care Management Association. He belongs
to a number of pharmacy organizations, including the Academy of Managed
Care Pharmacy andthe Michigan Pharmacy Association. Mr. Winkelman is a
registered pharmacist and holds a Bachelor of Science Degree in Pharmacy
from Wayne State University.
Arthur P. Bedrosian, J.D. was elected President of the Company in
May 2002 and CEO in January of 2006. Prior to this, he served as the
Company’s Vice President of Business Development from January 2002 to
April 2002, and as a Director from February 2000 to January 2002. Mr.
Bedrosian has operated generic drug manufacturing, sales, and marketing
businesses in the healthcare industry for many years. Prior to joining the
Company, from 1999 to 2001, Mr. Bedrosian served as President and Chief
Executive Officer of Trinity Laboratories, Inc., a medical device and drug
manufacturer. Mr. Bedrosian also operated Pharmaceutical Ventures Ltd, a
healthcare consultancy and Interal Corporation, a computer consultancy
to Fortune 100 companies. Mr. Bedrosian holds a Bachelor of Arts Degree
in Political Science from Queens College of the City University of New York
and a Juris Doctorate from Newport University in California.
Garnet Peck, PhD, was elected a director of the Company in
September2005. Dr. Peck is Professor Emeritus of the Industrial and
Physical Pharmacy department at Purdue University, where he has held
numerous positions since 1967. Earlier in his career, Dr. Peck served as
senior scientist and group leader at Mead Johnson Research Center and
as a Pharmacist in the United States Army. Dr. Peck has also consulted
for some of the largest pharmaceutical companies in the world and served
on several committees of the United States Food and DrugAdministration.
Dr. Peck has chaired numerous pharmaceutical conferences and is a
published author and frequent lecturer. He earned his Bachelor of Science
Degree in Pharmacy, with distinction, from Ohio Northern University, and a
Master of Science degree and Doctorate Degree in Industrial Pharmacy
from Purdue University.
Kenneth Sinclair, PhD, was elected director of the Company in
September 2005. Dr. Sinclair is currently Professor and Chair of the
Accounting Department at Lehigh University, where he began his academic
career in 1972. Dr. Sinclair has been recognized for his teaching innovation,
held leadership positions with professional accounting organizations and
served on numerous academic and advisory committees. He has received a
number of awards and honors for teaching and service, and has researched
and written on a myriad of subjects related to accounting. Dr. Sinclair
earned a Bachelor of Business Administration degree in Accounting, a
Master of Science degree in accounting and a Doctorate Degree in
Business Administration from the University of Massachusetts.
Jeffrey Farber was elected director of the Company, Inc in May 2006.
Jeffrey Farber joined the Company in August 2003 as Secretary. For the
past 13 years, Mr. Farber has been President and the owner of Auburn
Pharmaceutical (“Auburn”), a national generic pharmaceutical distributor.
Prior to starting Auburn, Mr. Farber served in various positions at Major
Pharmaceutical (“Major”), where he was employed for over 15 years. At
Major, Mr. Farber was involved in sales, purchasing and eventually served
as President of the mid-west division. Mr. Farber also spent time working
at Major’s manufacturing division — Vitarine Pharmaceuticals — where he
served on its Board of Directors. Mr. Farber graduated from Western
Michigan University with a Bachelors of Science Degree in Business
Administration and participated in the Pharmacy Management Graduate
Program at Long Island University. Mr. Farber is the son of William Farber,
the Chairman of the Board of Directors and the principal shareholder of
the Company.
